{"title": "PDF", "author": "PDF", "url": "https://www.vetmeduni.ac.at/hochschulschriften/diplomarbeiten/AC09597490.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " \n \n \nVeterin\u00e4rmedizinische Universit\u00e4t Wien \n \n \nForschungsinstitut f\u00fcr Wildtierkunde und \u00d6kologie \nLeitung: O. Univ. Pr of. Dr. Walter Arnold \n \n     \nComparison of S(+)-ketamine and ketamine,  \nwith medetomidine, for field anesthesia in the \nEuropean brown hare ( Lepus europaeus ) \n \n \n \n \n  \nDIPLOMARBEIT \n \n  \nzur Erlangung der W\u00fcrde des \nDiplom Tierarztes \n \n \nvorgelegt von \n \nHanno Gerritsmann \n \n \n \n \n \n2 \n Betreuer:  \n  \nUniv. Prof. Dr. Chris Walzer  Forschungsinstitut f\u00fcr Wildtierkunde und \u00d6kologie  Veterin\u00e4rmedizinische Universit\u00e4t Wien\n  \n \n \nGutachterIn:  \nP.D. Dr. habil. Eva Ebersp\u00e4cher \nKlinik f\u00fcr An\u00e4sthesiologie und perioperative Intensivmedizin  Veterin\u00e4rmedizinische Universit\u00e4t Wien \n \n \n \n \n     \n \n   \n \n  \n \n     \n \n \n \n    \n \n  \n3 \n  \n \n     \n \n     \n \n \n     \nA\nLL JENEN , DIE ES MIR AUF UNTERSCHIEDLICHSTEM WEGE  \nERM\u00d6GLICHTEN DIESE ARBEIT ZU SCHREIBEN . \n \n   \n4 \n Inhaltsverzeichnis  \n \nSeite \n1. E i n l e i t u n g             5  \n2. Manuskript f\u00fcr die Einreichung (Vet erinary Anesthesia and Analgesia) \n2.1       A b s t r a c t         1 2  \n2.2       Introduction        14 \n2.3       Materials & Methods      15 \n2.4       R e s u l t s         1 9  \n2.5       Discussion        21 \n2.6       Acknowledgements      26 \n2.7       References        27 \n2.8       T a b l e s         3 0  \n2.9       F i g u r e s         3 3  \n3. S u m m a r y            4 0  \n4. Z u s a m m e n f a s s u n g          4 1  \n \n \n \n \n \n   \n5 \n Einleitung \nDer Europ\u00e4ische Feldhase (EFH) ( Lepus europaeus ) geh\u00f6rt zur Ordnung der Hasenartigen \n(Lagomporpha ) und zur Familie der Hasen ( Leporidae ). Derzeit sind 79 Spezies innerhalb der \nOrdnung bekannt, wovon 19 von der International Union for Conservation of Nature and \nNatural Resources (IUCN) als gef\u00e4hrdet ei ngestuft sind (Grizmek 2003). Eines der am \nst\u00e4rksten gef\u00e4hrdeten S\u00e4ugetiere \u00fcberhaupt ist der  Buschmannhase ( Bunolagus monticularis).   \nDer EFH ist im Bereich der Wildtierforschun g, insbesondere hinsichtlich seiner Genetik \nsowie Reproduktion und Physiologie, seit langem von Interesse. Am Forschungsinstitut f\u00fcr \nWildtierkunde und \u00d6kologie (FIWI) der Veterin\u00e4r medizinischen Universit\u00e4t Wien wird die \nArt seit 25 Jahren  f\u00fcr Studienzwecke gehalten. \nIm Mai 2010 kam es aus ungekl\u00e4rter Ursache zu einer Bestandsinfektion mit Pasteurellen, \nBordetellen und mucoiden E.Coli, die seuchenhaft fortschritt und in deren Verlauf 15 Hasen \nverstarben. Aus diesem Grund wurde vom Institut f\u00fcr Bakteriologie, Mykologie und Hygiene \nder Veterin\u00e4rmedizinischen Universit\u00e4t Wien ei ne stall-spezifische Vakzine hergestellt. Zum \nZeitpunkt der Impfung wurde eine Blutprobe zur sp\u00e4teren Antik\u00f6rper-Titerbestimmung \ngenommen. \nLagomorphe gelten generell als sehr stressemp findlich (West et al. 2009). Da die Feldhasen \ndes FIWI keinen Kontakt zum Menschen gewohnt sind, m\u00fcssen die Tiere zur routinem\u00e4\u00dfigen \nmedizinischen Versorgung an\u00e4sthesiert werden. So auch f\u00fcr diese Blutentnahme. \nIn der Literatur gibt es keine Empfehlungen oder gar ein Standardprotokoll f\u00fcr die Feldhasen-\nNarkose. Eine direkte \u00dcbertragung von Erfahrungen aus der Kaninchen An\u00e4sthesie ist \ngrunds\u00e4tzlich kritisch zu betrachten, da es s ich um verschiedene Arten handelt (West et al. \n2009). \nIn der Literatur fanden sich Feldhasen Studie n, die auch invasive Ma\u00dfnahmen beinhalteten. \nSo wurde von Gustavsson (1972) eine unila terale Kastration von adulten Feldhasen \nausschlie\u00dflich unter Lokalan\u00e4sthesie mit Lidocain durchgef\u00fchrt. Caillol et al. (1992) f\u00fchrten \nunter Thiopental-Mononarkosen La parotomien durch. R\u00f6llig (2008)  fixierte die Tiere manuell \ndurch zwei Personen und benutze Maskeneinlei tung sowie Erhaltung mit Isofluran als \nAn\u00e4sthesieprotokoll f\u00fcr ihre Untersuchunge n. Diese Techniken sind ohne Zweifel f\u00fcr \nchirurgische Eingriffe nicht mehr zeitgem\u00e4\u00df. Kombinationen aus Ketamin und einem \u03b1\n2-Agonisten sind in der Wildtieran\u00e4sthesie weit \nverbreitet und wurden bereits bei diversen Spezies erfolgreich eingesetzt (West et al. 2009).  \n  \n6 \n Ketamin \nKetamin geh\u00f6rt chemisch zu den Cyclohexanderivaten. In der An\u00e4sthesie f\u00e4llt es neben \nTiletamin in die Klasse der dissoziativen An\u00e4sthet ika. Patienten, die mit Ketamin an\u00e4sthesiert \nsind,  erscheinen in einem kataleptoiden Zusta nd, der durch Muskelstarre, aber gute Analgesie \nund Amnesie gekennzeichnet ist (Riviere & Papich 2009). Die dissoziative Wirkung kommt \ndurch die unterschiedlichen Wirkorte de s Ketamins zustande. Thalamoneokortikale \nLeitungsbahnen werden, bei gleichzeitiger Stim ulierung limbischer Areale, gehemmt (Kress \n1997).  \nDas in der Tiermedizin klinisch verwendete Ketaminhydrochlorid stellt eine gleichteilige \nMischung seiner beiden Stereoisomere S-(+)- bzw. R-(-)-Ketamin, die sich stereoselektiv in \nihren Effekten unterscheiden, dar. Die Wirkungswei se der dissoziativen An\u00e4sthetika ist in den \nvergangenen Jahren immer weiter aufgekl\u00e4rt  worden. Ihre Hauptwirkung entwickeln beide \nKetamin Stereoisomere an der Phencyclidin (PCP)-Bindungsstelle im N-Methyl-D-Aspartat \n(NMDA)-Rezeptorkanal, einem postsynaptischen, ionotropen Glutamat-Rezeptor. Hier \nhemmen sie den Effekt der NMDA-Rezeptor A gonisten nicht kompetitiv. S-(+)-Ketamin hat \nbeim Menschen eine 3-4 fach h\u00f6here Affini t\u00e4t zur PCP-Bindungsstelle als das R-(-)-Isomer \n(Hempelmann & Kuhn 1997). Die Rezeptoraffinit\u00e4t der Isomere am PCP-Rezeptor im \nNMDA-Rezeptorkanal entspricht nicht nur deren inhibitorischen Eigenschaften, sondern \nerkl\u00e4rt auch das an\u00e4sthetische und analgetisc he Potential der Isomere sehr gut (Kress 1997). \nHochdosiertes R-(-)-Ketamin f\u00fchrt beim Me nschen mitunter zu Exzitationen und \nHalluzinationen. Dies legt eine Beteiligung de r ehemals als Opiat-Re zeptoren bezeichneten \n\u03c31,2-Rezeptoren, sowie der \u03ba-Opiat-Rezeptoren nahe. Ketaminwi rkung an Opiatrezeptoren ist \nnachgewiesen (Finck & Ngai 1982). Die Affini\u00e4t des S-(+)-Isomers an \u03bc- und \u03ba-Rezeptoren \nin Meerschweinchenhirn-Homogenat ist 2-4 mal h\u00f6her als die des R-(-)-Isomers und ist \ngenerell \u03bc>\u03ba>\u03b4 (Kress 1997). Generell ist die Affi nit\u00e4t zu den Opiatrezeptoren bei \u03bc-Rezeptor \n10 mal und bei \u03ba-Rezeptor 20 mal so hoch wie gegen\u00fcber der PCP-Bindungstelle. Heute wei\u00df \nman, dass die Ketaminwirkung an den Opiatrezptoren nur teilweise die analgetischen \nEigenschaften bedingt, da sie nicht vollst\u00e4ndig durch Naloxon antagonisierbar ist (Kress \n1997). Weiterhin hat Ketamin Einfluss auf ni kotinische Acetylcholin Rezeptorkan\u00e4le \n(nAChR) und muskarinische Acetylcholinrezeptoren (mAChR), sowie die Aussch\u00fcttung und \nRe-uptake der Neurotransmitter Noradrenalin  und Dopamin. Durch direkte Beeinflussung von \nspannungsgesteuerten Natriumkan\u00e4len er zielt Ketamin weiterhin seine bekannten \nlokalan\u00e4sthetischen Effekte (Kress 1997).  \n7 \n Ketamin wird haupts\u00e4chlich durch mikrosomale En zyme in der Leber abgebaut. Es erfolgt \neine N-Demethylierung zum aktiven Metaboliten  Norketamin, welcher zum Teil hydroxiliert \nwird. Sowohl Norketamin als auch Hydroxynorketamin werden zu wasserl\u00f6slichen \nGlucuroniden konjugiert und mit dem Urin ausges chieden (White et al. 1982). Hierbei wird \ndas S-(+)-Enantiomer um 20% schneller meta bolisiert als das R-(-)-Enantiomer. Dieses \nwiederum wird um 10% schneller metabolisier t als das Razemat (Kharasch & Labroo 1992). \nKharasch & Labroo (1992) zeigten, dass bei al len Konzentrationen (gleiche Anzahl von \nKetamin-Molek\u00fclen) das Razemat langsamer abgebaut wird als die Enantiomere jeweils \neinzeln. Dem liegt eine gegenseitige Hemm ung des Abbaus zugrunde, was eine k\u00fcrzere \nWirkdauer von S-(+)-Ketamin erkl\u00e4ren w\u00fcrde. \n \n\u03b12-Agonisten \nAlle \u03b12-Agonisten, mit Ausnahme des Xylazins, geh\u00f6ren chemisch in die Gruppe der \nImidazole. Generell haben die \u03b12-Agonisten sowohl sedierendes als auch analgetisches und \nmuskelrelaxierendes Potential (Riviere & Papich 2009). \n\u03b12-Agonisten wirken unter anderem an \u03b12A-Rezeptoren, die (G Protein vermittelt) Typ-N \nCalciumkan\u00e4le schlie\u00dfen und zur Hyperpolarisat ion der pr\u00e4- und postsynaptischen Zelle \nf\u00fchren. Dadurch kommt es zur Inhibition des positiven Feedbacks und damit zu reduzierter \nAussch\u00fcttung von Noradrenalin aus der pr\u00e4synap tischen Zelle in den synaptischen Spalt. \n\u00dcber die reduzierte  Aussch\u00fcttung von Noradrenalin, vor allem im Locus coeruleus und \nHypothalamus, aber auch anderer Bereiche des Ge hirns, wird letztlich die sedierende \nWirkung erzielt (Riviere & Papich 2009). Die \u03b12-Agonisten vermittelte Analgesie kommt, \nsoweit derzeit bekannt, durch den gleichen Prozess im Zentralnervensystem (ZNS) zustande. \nJe nach Art der Verabreichung sind Rezeptoren im Locus coeruleus  und in der Substantia \ngelatinosa  des Dorsalhorns des R\u00fcckenmarks invol viert oder, bei epiduraler Anwendung, \nhaupts\u00e4chlich die  Rezeptoren in der Substantia gelatinosa  des Dorsalhorns (Riviere & Papich \n2009). \nDas derzeit noch \u00fcberwiegend genutzte razemisc he Medetomidin liegt als Gemisch aus 2 \nEnatiomeren vor, wobei sich ausschlie\u00dflich das D-Isomer als pharmakologisch wirksam \nerwiesen hat (Kharasch et al. 1992). Das L-Iso mer scheint als kompetitiver inverser Agonist \nzu wirken (es setzt am gleichen Rezeptor an, ab er reduziert seine Aktivit\u00e4t (Riviere & Papich \n2009), was m\u00f6glicherweise die Wirksamkeit des Razemats beeinflusst. Beide Isomere haben \nzudem starken Einfluss auf den hepatischen Abba u anderer Pharmaka (Kharasch et al. 1992).   \n8 \n Bei vorhergegangen An\u00e4sthesien der Feldhasen des Instituts mit dieser Kombination wurde \ntrotz Antagonisierung der \u03b12-Komponente mitunter langer Nachschlaf (recovery time) \nbeobachtet. Insbesondere hinsichtlich eines f\u00fcr die Feldan\u00e4sthesie geeigneten Protokolls sind \nRegenerationszeit sowie unerw\u00fcnschte Nebenwirkungen m\u00f6glichst gering zu halten. \nAuf Grund entsprechender Literatursuche wurde die Hypothese entwickelt, dass die Nutzung \nvon S-(+)-Ketamin statt razemischem Ketamin nebe n einem \u00e4quivalenten, f\u00fcr chirurgische \nEingriffe  geeigneten, An\u00e4sthesiestadium auch  den Vorteil einer k\u00fcrzeren Aufwachphase mit \nweniger unerw\u00fcnschten Nebenwirkungen produzier en k\u00f6nnte (White et al. 1980; White et al. \n1982; Erhardt et al. 2001; Kili\u00e7 & Henke 2004; Rossetti et al. 2008). \nDemzufolge wurden beide Protokolle hinsichtl ich signifikanter Unterschiede, mit besonderem \nAugenmerk auf die Parameter der Aufwachphase, verglichen.  \nIn Anlehnung an g\u00e4ngige Praktiken der veterin\u00e4rmedizinischen An\u00e4sthesie wurden folgende \nParameter zur vergleichenden Beurteilun g der Narkosezeiten herangezogen.  \n \n \nTab. 1a : Parameter der Aufwachphase \n \nParameter Englisch Definition \nErstreaktionszeit  Reaction time  Zeit (Minute n) Applikation bis erste Reaktion auf \nMedikation  \nWirkungszeit  Time until full effect  Zeit (Minuten) Applikation bis Verlust des Stellreflexes  \nNarkosezeit  Total anesthesia \ntime Zeit (Minuten) Applikation bis zum ersten selbstst\u00e4ndigen   \nAnheben des Kop fes \nAufstehzeit  Standing time  Zeit (Minuten) von Antagonisierung bis zum Zeitpunkt, an \ndem das Tier auf vier Beinen steht  \nRegenerationszeit  Recovery time  Zeit (Minuten) ab Aufstehzeit bis zur v\u00f6lligen \nAbwesenheit aller Zeichen einer An\u00e4sthesie  \n Um ein m\u00f6glichst objektives Ma\u00df f\u00fcr eine  potentiell erh\u00f6hte Motoraktivit\u00e4t bei der \nVerwendung von razemischen Ketamin zu erhalten, wurden noch folgende Parameter \nhinzugef\u00fcgt. Es wurde eine Strichliste \u00fcber die Anzahl der Vorg\u00e4nge gef\u00fchrt.  \n  \n9 \n  \nTab. 1b.: Zus\u00e4tzliche Parameter der Aufwachphase nach Gabe von Ketamin respektive \nS-(+)-Ketamin \nParameter Englisch Definition \nUmfallen  Falling over  Aus stabiler P osition oder im Zuge einer Bewegung \numfallen  \nAuf der Seite \nrudern  Pedaling on the side  Auf der Seite liegend u nkoordiniert rudern \n(Aufrichtev ersuche)  \n \n \n \nAbschlie\u00dfend wurde die Aufwachphase mit Hilf e einer Visual Analoge Scale (VAS), mit \nfolgender Begrenzung, subjektiv beurteilt. \n \nGrafik 1.: \n \n                          Sehr schlecht                                                                              Perfekt    \n \nMit Hilfe der oben erw\u00e4hnten Parameter wu rde versucht, durch die Kombination von \nobjektiven und subjektiven Ma\u00dfen, eine bestm\u00f6gl iche Beurteilung der An\u00e4sthesie, sowie der \nAufwachphase zu gew\u00e4hrleisten. Die Parameter wurden, in Ermangelung umfangreicher \nLiteratur bez\u00fcglich Fel dhasenan\u00e4sthesie, in Anlehnung an Grunds\u00e4tze der Wildtieran\u00e4sthesie \n(West et al. 2009), sowie einschl\u00e4giger Fachliteratur (Portier et al. 2010) gew\u00e4hlt. \nUm Beeinflussung der beteiligten An\u00e4sthesisten m\u00f6glichst gering zu halten, wurden diese \nbez\u00fcglich der jeweils verwende ten Wirkstoffe geblendet.  \nDer Fragestellung, ob Kombinationen von Medetomidin mit S-(+)-Ketamin Vorteile, \ninsbesondere hinsichtlich der Aufwachphase, gegen\u00fcber der Kombination von Medetomidin \nund razemischen Ketamin aufweist, wurde nach Ab schluss der Planungst\u00e4tigkeiten in einem \nzweiw\u00f6chigen, praktischen Teil  ab dem 27.10.2010 nachgegangen. \n \n  \n  \n10 \n Literatur:   \nSiehe Manuskript - References \n \n \n \n  \n11 \n Manuskript f\u00fcr die Einreichung  \n \nThe m anuscript will be submitted to the journal \u201eVeterinary Anesthesia and Analgesia\u201d in \nJanuary 2011. \n \nComparison of S(+)-ketamine and ketamine, with medetomidine, for field anesthesia in \nthe \nEuropean brown hare ( Lepus europaeus ) \n \nAuthors: Hanno Gerritsmann \u00b9, Gabrielle Stalder, Mag. med. vet. \u00b9, Katharina Seilern-\nMoy \u00b9, Felix Knauer Dr. silv. \u00b9 and Chri s Walzer, Dr. med. vet., Univ. Prof. \u00b9  \n \n\u00b9 Research Institute of Wildlife Ecology, Un iversity of Veterinary Medicine, A-1160 Vienna, \nAustria \n \n \nCorresponding author:   \nHanno Gerritsmann   \nResearch Institute of Wildlife Ecology  \nUniversity of Veterinary Medicine  \nA-1160 Vienna  \nAUSTRIA  \nPhone: +43 650 3805011 \nE-mail: hanno.gerritsmann@fiwi.at \n \nKeywords  field anesthesia, European brown hare, S(+)-ketamine,  Lepus europaeus , \nmedetomidine, atipamezole \n \n \n \n  \n \n  \n12 \n  \nAbstract \nObjective \nTo compare the induction, achievement of surgical anesthesia, cardiopulmonary effects and \nespecially recovery quality of racemic ketamine or S(+)-ketamine when used in combination \nwith medetomidine for intramuscular (IM) field anesthesia in the European brown hare (EBH) \n(Lepus europaeus ). \n \nStudy design Randomized, prospective, bl inded clinical trial. \n \nAnimals  20 adult European brown hares (10 male, 10 female) with a body mass of 3360 (\u00b1 \n341) grams. \n \nMethods Medetomidine (0.2 mg kg-1) and ketamine (30 mg kg-1) (K-M group) or S(+)-\nketamine (15 mg kg-1) (S-M group) were administered by IM  injection. Time until first effect \nand loss of righting reflex were recorded. During maintenance heart rate (HR), saturation of \narterial hemoglobin (SpO 2), respiratory rate (RR), side stream expiratory CO 2 (etCO 2), non \ninvasive blood pressure, body temperature (temp), palpebral reflex, jaw tone and pain \nsensation were recorded every five minutes. 45 minutes after injection of the medication, \nmedetomidine was antagonized with atipamezole (1 mg kg-1). Time until first head lift, time \nuntil standing and total recovery time (T-Recov) were recorded. Incidences of falling over to \nthe side (falling) and pedaling while in later al recumbency (pedaling) during recovery were \ncounted for each animal. A visual analogue s cale (VAS) was used to determine the subjective \nimpression of recovery quality. Mean weight, time until first effect and loss of righting reflex, \nHR, SpO 2, etCO 2, temp as well as the recovery para meters falling, pedaling, T-Recov and \nquality were compared using an unpaired t-test. Mean values for all other data were compared \nusing a Mann-Whitney test. \n \nResults Induction was similar in both groups. During maintenance respiratory parameters \nwere significantly better for the S-M group. Surgical anesthesia was achieved at significantly \nmore points of measurement in the K-M group (56.3 \u00b1 9.2%) vs. the S-M group (42.5 \u00b1 \n12.8%). During recovery, animals of the S-M group (12.5 \u00b1 6.7) fell over to the side less often  \n13 \n than animals of K-M group (27.2 \u00b1 12.6). Overal l, T-Recov did not differ significantly \nbetween groups and was long, lasting for more than three hours in some animals. \nConclusion and clinical relevance S(+)-ketamine showed only minor advantages over \nracemic ketamine, surgical anesthesia was not ach ieved reliably with either protocol. Both, \nracemic- and S(+)-ketamine in combination wi th medetomidine, at the dosages used, are \nconsidered inadequate for field anesthesia in th e EBH. Further research is needed to develop \nan injectable protocol that allows surgical procedures and rapid recoveries.  \n \nKeywords:  field anesthesia, European brown hare, Lepus europaeus , S(+)-ketamine, \nmedetomidine, atipamezole \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n  \n14 \n Introduction  \nThe European brown hare (EBH) ( Lepus europaeus ) belongs to the order of Lagomorphs and \nis a species distributed widely from northern Sp ain through western and central Europe to the \nnorthwestern parts of Mongolia (Grizmek 2003) . Introduced populations are found in several \nparts of the world including Australia, New Ze aland, southern South America and parts of the \nUnited States of America (Grizmek 2003). \nIn the past, the EBH has been the subject of numerous research questions, including studies \non reproduction (Gustavsson 1972; Caillol et al. 1992; R\u00f6llig 2008 ) which included invasive \ntechniques. Even though literature concerning anesthesia in rabbits is common, specific \ninformation concerning anesthesia in the EBH is very scarce.  \nCaillol et al. (1992) used thiopenthone at 20 mg kg-1 when performing laparotomy and \nGustavsson (1972) performed unilateral orchiecto my in adult males under local anesthesia \nwith xylocaine. R\u00f6llig (2008)  restrained animals physically with two assistants, while a third \ninduced anesthesia with 5% isoflurane via face-mask. Subsequently, anesthesia was \nmaintained with 1 - 1.5% isoflurane. West et  al. (2009) encourage box induction over mask \ninduction for Lagomorphs. \nIn any case, isoflurane anesthesia alone cannot be considered adequate for surgery since it \ndoes not provide sufficient analgesia (West et al . 2009; Erhardt et al. 2004). Furthermore, in a \nfield setting, administration of isoflurane migh t be impracticable and an induction box for an \nadult EBH would have to be qui te large and stable since this species is larger than most \nrabbits and of respectable strength when stressed and attempting to escape. \nThe objective of this study was to compare two simple injectable anesthetic protocols for field \nanesthesia in the EBH in order to obtain an improved recovery phase, while producing safe \nand adequate anesthesia for invasive procedures.  \nKetamine combined with \u03b12-agonists had previously been used for procedures involving the \nanimals routinely held at the Institute of Wi ldlife Ecology (University of Veterinary \nMedicine, Vienna, Austria). During these procedures, long recovery times had been noted.  \nSince a short recovery is an important factor in  wild animal anesthesia, it was decided to \ncompare a racemic ketamine \u2013 medetomidine protocol with a S(+)-ketamine \u2013 medetomidine \nprotocol. It has been reported previously in other species that S(+)-ketamine has significantly \nless undesired side effects regarding recovery  than racemic ketamine (White et al. 1982; \nErhardt et al. 2001; Kili\u00e7 & Henke 2004; Rossetti et al . 2008). \n  \n15 \n Materials & Methods \nIn October 2010, 89 European brown hares ( Lepus europaeus ) held routinely by the Institute \nof Wildlife Ecology (University of Veterina ry Medicine, Vienna, Austria = UVMV) needed \nto be vaccinated with an enclosure-specific vaccine against Pasteurella and Bordetella  \nproduced by the Institute for Bacteriology, Mycology and Hygiene (University of Veterinary \nMedicine, Vienna, Austria). Additionally, 5 ml  of blood were drawn from 54 hares from the \nleft jugular vein for antibody titer assessment.  \nThe hares are individually housed in wooden cages with grid flooring, inside an open stable. \nTemperatures in the cages correspond to outside environmental temperatures. Floor area is 0.5 \nm\u00b2 per animal. All hares are fed on specially p roduced hare pellet diet (Hasenfuttermittel, \nRaiffeisenverband Salzburg, Austria). \n \nThe study described in this publication was part of the routine clinical work of the institute \nand noted and approved by the UVMV ethics co mmission. In addition, all trials described \nwere in concordance with Austri an animal welfare legislation. \n \nOf the 54 hares used for antibody titer assessmen t, 20 adult hares of both sexes (n = 10 males, \nn = 10 females) with a mean body mass of 3.36 \u00b1 0.34 kg were randomly assigned to either \none of the following groups: \n S-M (receiving S(+)-ketamine and medetomidine)  \n K-M (receiving racemic ke tamine and medetomidine)  \nSince literature on EBH anesthesia was scarce and to the author \u2019s best knowledge no \nscientifically performed anesthetic protocol in cluding either agent was available, the day \nbefore the study, 2 animals were anesthetized for antibody titer assessment using 10 mg kg-1 \nS(+)-ketamine and 100 \u03bcg kg-1 medetomidine. Immobilization was accomplished, but state of \nanesthesia was light. Only after this it was d ecided to increase dosages to those employed in \nthe study. \n \nOn the days of the procedure each individual wa s caught from its cage with a catch box of \nknown weight, made specifically for this purpose . Immediately thereafter the animal was \nweighed within the box and the box then placed  on the floor with the grid opening in contact \nwith a wall to reduce possible ex citation by audiovisual stimuli . All hares in the study \nappeared clinically healthy on visual and behavioral adspection. The animal's mental  \n16 \n condition was evaluated by observing attempts to escape from the catch box by eagerly \nscratching the walls. Two distinctions were mad e: calm vs. excited. Animals were recorded as \ncalm when the scratching ceased after one mi nute of being put on the floor. If scratching \ncontinued for a longer period of time the animals were marked as excited. \n \nSubsequently, the catch box was placed on a table  and the hare was physically restrained by \nan experienced assistant for drug applicati on. Additionally, treatment order was randomized \nand the observers blinded. Each animal underwent anesthesia once. \nRacemic ketamine (100 mg ml-1; Ketasol; Graeub, Berne, Switzerland) or S(+)-ketamine (25 \nmg ml-1; S Ketanest; Pfizer, Vienna , Austria) were combined with medetomidine (10 mg ml-1; \nZalopine; Orion Pharma, Espoo, Finland). \n Group K-M received: Medetomidine (0.2 mg kg-1) and ketamine (30 mg kg-1)  \n Group S-M received: Medetomidine (0.2 mg kg-1) and S(+)-ketamine (15 mg kg-1) \nDrugs were mixed in a syringe and then given as  a single IM injection into the caudo-lateral \naspect of the pelvic limb ( m. biceps femoris). The maximal injected volume was less than 2.5 \nml. \nTo achieve equal injectable volumes with both protocols, racemic ketamine was diluted to 50 \nmg ml-1 with aqua bidest (Aqua ad injectionem; Braun B., Maria Enzersdorf, Austria). \nAfter injection, the hare was immediately released  from physical restrain t and left in the catch \nbox until full effect. During this time the grid  was facing the corner of the procedure-room. \nThe observer kept a distance of 3.5 m to the box, closely monitoring any changes in behaviour \nof the animals. \nFirst effect, as well as loss of  righting reflex were recorded. Righting reflex was evaluated by \nslowly tilting the catch box 90\u00b0 to the contra-lateral side of the animal \u2019s body position. When \nno reaction was present, the righting reflex co unted as negative. Time of loss of righting \nreflex was tested with a potential error of 20 seconds as the animal was only approached \nevery 20 seconds to minimize potential flight behavior. \nAfter loss of righting reflex the hares were lef t in the catch box for an additional 2 minutes to \nallow the anesthetics to gain full effect.  In case of spontaneous movement upon opening, \nanimals were left in the catch box for another 5 minutes until full effect was evident. \nThe hares were then placed in right lateral recumbency. Eye ointment (Oleovit; Fresenius \nKabi, Graz, Austria) was applied to the cornea to avert drying. To counteract a decrease in \nbody temperature all hares were placed on a heating pad. Non invasive arterial blood pressure  \n17 \n (systolic arterial pressure = S AP, mean arterial pressure = MAP and diastolic arterial pressure \n= DAP), body temperature (temp), satura tion of arterial hemoglobin (SpO2), side stream ET \nCO2  (etCO2) as well as pulse frequency and respiratory rate (RR) were measured using a \nMindray PM-8000 Express, patient monitor (Mindray, China). \nNIBP was measured proximal of the left elbow (Ypsilantis et al. 2005). Body temperature was \nmeasured with a rectal probe which was inserted four centimeters in all animals. The pulse-\noximeter probe was placed on the animals tongue. The tube for side stream ET CO2 \nmeasurement was placed in the hare's left nostril for 1 minute every five minutes.  \nPalpebral reflex was tested for anesthetic depth by touching the naso-ventral canthus of the \neye up to three times within 10 s. Compressing the P2 of the fourth digit of the left thoracical \nlimb with a hemostat, engaged to first pitch three times within 20 seconds, was used for the \nevaluation of pain sensation. Surgical anesthesia  was judged to be present in the absence of \nreaction (increase of HR, RR, or movement) to  the third compression (Hedenqvist et al. 2001; \nKili\u00e7 & Henke 2004). Muscle relaxation was evalu ated by checking jaw tone. All reflexes and \njaw tone were always evaluated by the same person, blinded to the drug combination used. \n \nTime at injection of the anesthetics was de fined as T = 0 min. Evaluation of first \nphysiological parameters and reflexes was dependent on induction time. In the S-M group \nfirst measurements were made six times at T = 10 min, three times at T = 15 min and once at \nT = 20 min. In the K-M group first measurements  were made eight times at T = 10 min and \ntwice at T = 15 min.  From the onset of measurements, reflexes and physiological variables were recorded every \nfive minutes until T = 45 min. At this time,  medetomidine was antagonized with 1 mg kg\n-1 \natipamezole (5.0 mg ml-1; Antisedan; Orion Pharma, Espoo, Finland). \nFollowing atipamezole application, the hares were  returned to their cages. After four animals \na case of high grade excitations was noted and subsequently a padded and darkened wake up \nbox was constructed. All remaining 16 animals were placed in this wake up box for recovery \nand closely monitored.   \nDuring recovery, the following variables were monitored by two anesthetists blinded about \nthe protocol: \nChewing, lift head time (T-Anesth = time from T = 0 until the first complete lift of the head), \nstanding time (T-standing = time from antagoni zation until the animal stood on four feet for \nthe first time) and recovery time (T-Recov = ti me until the animal was sitting alert and  \n18 \n moving in a coordinated way, without showing signs of ataxia or anesthesia). Additionally, \nthe number of times the hare fe ll over and pedaling while in lateral recumbency were taken as \na measure of recovery status by counting the events  for 135 minutes post antagonization. As \na measure for the subjective quality of the rec overy phase, the blinded anesthetist supervising \nthe recovery phase placed a mark on a visual analogue scale (VAS). The scale was 100 mm \nlong and anchored with \u201cvery poor\u201d and \u201cperfect\u201d.  \n \nStatistical Analysis \nStatistics were done using the Program R 2.9.2 (The R Foundation for Statistical Computing, \nAuckland, NZ ). Each dataset was tested for normal distribution using a Shapiro-Wilk \nnormalitiy test. Since sample size was small, data were also plotted for normal distribution \nassessment. Mean values were compared using an unpaired t-test. Mean values for data that \nwere not normally distributed were compared using a Mann-Whitney test.  \n \n \n   \n \n \n \n \n \n \n \n  \n \n \n \n  \n19 \n Results \nPre-anesthetic evaluation \nThere were no significant differences between groups regarding weight or the number of \nexcited animals vs. the number of calm animals (Table 1). \n \nInduction of Anesthesia \nKetamine or S(+)-ketamine and medetomidine were administered successfully to all animals \nvia IM injection (into the m. biceps femoris ). When comparing first effect and the time to loss \nof righting reflex between the two groups, the S-M group tended to have a marginally shorter \ntime until first effect than animals in the K-M group. Conversely, animals receiving racemic \nketamine tended to have a slightly shorter time  until loss of righting reflex. However, \ndifferences were not significant (Figure 1). \n Maintenance \nOverall mean values of physiological parameters are shown in Table 2. Physiological \nparameters over time are shown in Figures 2 a) - d). During the maintenance/duration of \nanesthesia mean values of HR (Figure 2a)), SAP (Figure 2b)) and body temperature did not \ndiffer significantly between groups. In two animals of the K-M group cardiac arrhythmia  \n(differing from respiratory arrhythmia)  was recorded at the beginning of anesthesia. No pulse \ndeficit was recorded during these episodes. \nYet, mean respiratory parameters differed significantly between groups. Side stream ET CO\n2 \n(Figure 2c)) was significantly (p = 0.02) lower in the S-M group than in the K-M group (39 \u00b1 7 vs. 41 \u00b1 5 mmHg respectively). RR (Figure 2d)) in the S-M group was significantly (p = \n0.03) higher than in the K-M group (40 \u00b1 16 vs. 34 \u00b1 12 respectively). SpO\n2 was significantly \n(p = 0.03) higher in the S-M group when compared to the K-M group (82 \u00b1 6 vs. 79 \u00b1 9 \nrespectively). \n \nThe percentage of animals with adequate mus cle relaxation did not differ significantly \nbetween groups (p = 0.74). \nMean percentage of animals that achieved su rgical anesthesia was significantly (p < 0.03) \nhigher in the K-M group (56.25 \u00b1 9.2%) than in the S-M group (42.5 \u00b1 12.8%) (Figure 3). \nPalpebral reflexes ranged from spontaneous bl inking to delayed reaction but were maintained \nin all animals. In six out of 154 measurements (3.9%) palpebral reflex was absent. In four out  \n20 \n of these six times (67%) this was immediately after induction. In the remaining two cases, \nabsence was noted at one point during anesthesia  but it was present at the measurement right \nbefore and after the noted absence.  \nAtipamezole was administered successfully via IM injection to all 20 hares in the study at  \nT = 45. \n \nRecovery \nChewing was observed in all animals before the first head lift. T-Anesthesia, T-Standing and \nT-Recovery are presented in Table 3. No si gnificant differences between groups were \nidentified. There was, however, an overall, non significant tendency for shorter times in hares \nof the S-M group (Figure 4). Falling events were significantly higher (p = 0.02) in the K-M \ngroup (27.2 \u00b1 12.56) than in the S-M group (12.5 \u00b1 6.7). The S-M group had overall less \npedaling events while in lateral recumbency, however, this was not significant (Figure 5). \nVAS values for recoveries, when compared betw een groups, were not significantly different. \nHere too, a trend towards better recovery for the S-M group was observed (Figure 4). \n \n   \n \n   \n \n   \n \n \n \n  \n21 \n Discussion \nAccording to this study, non surgical anesthesia in the EBH can be rapidly induced via IM \nadministration of a combination of  either racemic ketamine (30 mg kg-1) or S(+)-ketamine (15 \nmg kg-1) and medetomidine at 0.2 mg kg-1. The K-M group appeared to reach a deeper stage \nof anesthesia when compared to the S-M group. Respiratory parameters were significantly \nbetter in the S-M group. As reported in other sp ecies, these results suggest that S(+)-ketamine \ndoes not have an identical potency relationship to  the racemic mixture in EBHs as in humans \n(Marietta et al. 1977; Duque et al. 2008).  \n \nCardiovascular parameters during anesthesia were stable in both groups and did not differ in a \nclinically significant way. However, animals of both groups had long recovery times and \nsevere emergence reactions. S(+)-ketamine dem onstrated a tendency to improve recovery \nparameters, like the number of times  the animal fell over to the side and the pedaling events. \nHowever, the extent of this effect  is minimal and in the author \u2019s opinion does not offer major \nadvantages over racemic ketamine in this species. \n \nInjected volumes were relatively large at 0.52 ml kg-1 in both groups. Diehl et al. (2001) \nsuggest volumes of 0.25 ml kg-1 for IM injection with a maximal  injectable volume of 0.5 ml \nkg-1 in rabbits. Since hares differ morphologically from rabbits and sub-cutaneous injection is \nprone to produce complications in a struggling an imal, IM injection into the caudal aspect of \nthe pelvic limb was considered most suitable. This decision is supported by the fact that all \nhares tolerated injection well. The ban of IM ke tamine injections by the European Society of \nLaboratory Animal Veterinarians (ESLAV) be cause of pain upon injection and potential \nmuscle necrosis was noted. However, minimal hand ling time, fast and safe injection and rapid \ninduction led to IM injection as the only adequate route in this study. \nDosages were chosen based upon suggestions made  for rabbits (Flecknell 2009; Erhardt et al. \n2004). Attention was given to research done by Avsaroglu et al. (2003) who identified strain \nspecific differences in ketamine tolerance in  rabbits. Also Hunter & Isaza's (2008) study \nfocusing on interspecies scaling was considered and risks linked with interspecies adoption of \nanesthetic protocols (West et al. 2009) were taken into account.  \n \nInduction times for IM administered drugs (5 - 15 minutes) were within normal range (Muir et \nal. 2007). Drug dosages are inextricably linked with achievement of peak plasma  \n22 \n concentrations (Riviere & Papich 2009). Tenden cy towards shorter induction times (time until \nfull effect) in the K-M group could be attributed to the higher effective dose of ketamine. \nDuring anesthesia, no significant differences were identified in respect to cardiovascular \nparameters. This is in concorda nce with previous results of  comparative studies between \nracemic ketamine and S(+)-ketamine anesthesia made in mice (Kili\u00e7 & Henke 2004) and in \nhorses (Rossetti et al. 2008). The recorded arrhythmias in the K-M group at beginning of \nanesthesia were not further described since no ECG was recorded. A higher incidence of \narrhythmias when using racemic ketamine has been reported in humans (Hempelmann & \nKuhn 1997). However, medetomidine as all alpha-2 agonists has arrhythmic potential and \ncannot be ruled out having triggered the observed arrhythmias (Muir et al. 2007).  \nThe significantly higher respiratory rate in the S-M group versus the K-M group is most \nprobably due to the deeper stage of anesthesia  in the K-M group. Recently, Furtado et al. \n(2010) observed a decrease in respiratory rate during anesthesia in a group of black tufted \nmarmosets (Callithrix penicillata)  anesthetized with racemic ketamine in combination with \nmidazolam that was not observed in the group receiving S(+)-ketamine and midazolam. Even \nthough equimolar dosages of racemic ketamine a nd S(+)-ketamine were used by Furtado et \nal., their results should be taken into account. Ultimately, etCO2 and SpO2 are controlled by \nrespiration. The different RR recorded could be partially responsible for the different mean \nvalues of the parameters between groups. Due to  lack of other respiratory parameters (i.e. \nminute volume, etc.), this cannot be confirme d. The capnograph probe was only left in one \nnostril for one minute of each measurement si nce lagomorphs are primary to obligate nasal \nbreathers (West et al. 2009) and increased respir atory work was tried to be avoided. A deeper \nstage of anesthesia in the K-M group might also  hint that S(+)-ketamine possibly does not \nhave equal potency advantages over its racemic  mixture in the EBH as it does in humans. \nThe low SpO 2 values recorded by pulse oximetry c ould be due to hypoxemia. To the author \u2019s \nopinion, the extent of lower saturation in this stud y is more likely due to pulse oximetry errors \n(Hummler et al. 2006; Orr et al. 2005) or va soconstriction caused by medetomidine than \nactual saturation values. Unfortunately, this canno t be confirmed as no blood gas analysis was \nperformed in this study. Since a certain de gree of hypoxemia is anticipated, oxygen \nsupplementation should be considered if feasible under field conditions. \n \n In all animals, both anesthetic regimens pr oduced a sufficient state of anesthesia for blood \nsampling and non invasive measures that could be  of interest in the field. However, surgical  \n23 \n depth for possible implantation of very high fr equency (VHF) transmitters or probes was not \nreliably achieved with either racemic ketamine at 30 mg kg-1 nor S(+)-ketamine at 15 mg kg-1 \nin combination with medetomidine at 0.2 mg kg-1. Toe pinch, as a test for surgical anesthesia \ndepth, was positive in many animals after the second pinch only. This is supported by \nHedenqvist et al. (2001) and Kili\u00e7 & Henke (2004)  who found that if only a single nail pinch \nwas applied as a test for surgical anesthesia in rabbits, many animals would not have shown \nany reaction. \n \nIncreasing the dosage of either one or both of the anesthetics used could deepen anesthesia. \nSince palpebral reflexes were maintained and no  case of apnea occurred at the dosages used \nthis appears to be a suitable approach. Yet, it would increase anesthetic risk and injectable \nvolume. A deepening of anesthesia with isoflura ne as suggested by Flecknell (2009) and Orr \net al. (2005) is common practice but  often impracticable in field an esthesia situations. To the \nauthor \u2019s opinion infiltration or blocks with local anesthetics as suggested by Flecknell (2009) \nor adjunct of metamizol as suggested by Er hardt et al. (2004) should be considered.  \n \nThe results for palpebral reflex are to be critically evaluated since no consistent lack of \npalpebral reflex was recorded. When palpebral reflex was absent at the beginning of \nanesthesia, eye ointment had just been applied wh ich might have had an influence. It needs to \nbe stated generally that ocular (and other) reflexes are mostly maintained during ketamine \nbased anesthesia (Erhardt et al. 2004; Muir et al. 2007). \nNoticeable are the results for the recovery parame ters. Large differences concerning recovery \ntimes can be found in the literature about lagomorphs. West et al. (2009) state \u201c Ketamine has \na very short duration of clinical effect, owing, in  part, to redistribution and renal elimination\u201d \nwhereas Erhardt et al. (2004) report hangover times of up to 10 h for ketamine-xylazine \ncombinations in rabbits. Bjorkman & Redke (2000) found that in all the animal species within \ntheir study, except for the rabbit, ketamine c learance was lower than hepatic blood flow. \nWhereas, in the rabbit, ketamine showed extensive  extrahepatic clearance. Medetomidine is \nknown to significantly reduce hepatic micros omal metabolism of ketamine in human liver \nsamples in vitro (Kharasch et al. 1992). To the author \u2019s knowledge there is no study \nconcerning inhibition of extrahepatic ketamine- clearance in other species.  Duration of the \nEBH\u2019s recovery in our study encourages further investigation on this topic in the future.   \n24 \n Different information regarding time points of  partial antagonization of ketamine \u2013 \u03b12-agonist \ncombinations can be found in the literature. A tipamezole was administered at T = 45 min after \nadministration of the induction agents. This is  later than Flecknell (2009) at ketamine dosages \nof 15 mg kg-1 and sooner than Erhardt (2004) at dosages of 35 mg kg-1 suggest for rabbits.  \nTotal anesthesia times were similar but showed great variance in both groups with a mean of \n65 \u00b1 13 minutes in the S-M and 70 \u00b1 22 minutes  in the K-M group respectively. Get up time \non average was slightly shorter in the S-M group 30 \u00b1 25 vs. 34 \u00b1 23 minutes in the K-M \ngroup. Yet, ranges in both groups were considerably large.  \nOne animal in the study showed high grad e excitations starting at 75 minutes post \nantagonization and had to be caught again to su ture a skin lesion that occurred during the \nagitated behavior phase.  \nFor this reason a cushioned and darkened wake up box was constructed. In the following, all \nanimals were put in this box after antagoniza tion. Only one hare of the S-M group appeared \nfully recovered at 92 minutes post antagonization. All other hares had major hangover signs \nfor up to 180 minutes. When possible, monitoring was discontinued at 180 minutes post \nantagonization.  \nDuring recovery, the K-M group showed a markedly higher incidence of disorientation and \nlack of balance than the S-M group. This included running against walls and flipping over in \nsome cases. Ketamine is known to produce ataxia and increased motor activity during \nrecovery and this fact has been previously reviewed (Wright 1982). Higher incidences of \nunccordinated or involuntary movements when  using racemic ketamine in comparative \nstudies with S(+)-ketamine in different species have been reported previously (White et al. \n1982; Erhardt et al. 2001; Kili\u00e7 & Henke 2004; Larenza et al. 2008; Rossetti et al. 2008). \n \nThe VAS is a common tool used for the a ssessment of subjective impressions (Grint & \nMurison 2008; Portier et al. 2010). In this study it was taken as a measure for recovery \nquality. To reduce possible bias it was always done by the same anesthetist blinded about the \nprotocol. Yet, since no evaluation of anesthesia recovery in EBH had ever been performed \npreviously, expectations based on experience w ith recoveries in other species may have \ninfluenced results. However, it can be clea rly stated that overall recovery was inadequate \nespecially for field procedures.   \n  \n25 \n Using S(+)-ketamine had no clinically significant effect on anesthesia time. Less undesired \nside effects during recovery were recorded when S(+)-ketamine was used, but in general both \nprotocols produced long recoveries and no reliable surgical anesthesia. Therefore, at the \ndosages used, ketamine based anesthetic regimens (for field anesthesia protocols in particular) \nare not recommended for the EBH. In the author \u2019s opinion, ketamine is to be critically \nevaluated as an adjunct of anesthetic regimens in this species. If ketamine is used, a \ncompletely cushioned recovery box is necessary to avoid potential injuries such as skin \nlesions or even fractures. Not only for reliable achievement of surgical depth, but also for \nanimal welfare reasons further re search is needed to develop an anesthetic regimen suitable \nfor the EBH under field conditions.  \n26 \n Acknowledgements \nThe author would like to thank all the people involved in the realization of this study. \n   \n27 \n References \n Avsaroglu H, Versluis A, Hellebrekers LJ et  al. (2003) Strain differences in response to \npropofol, ketamine and medetom idine in rabbits. Vet Rec 152 , 300. \n Bjorkman S, Redke F (2000) Clearance of fen tanyl, alfentanil, methohexitone, thiopentone \nand ketamine in relation to es timated hepatic blood flow in  several animal species: \napplication to prediction of clea rance in man. J Pharm Pharmacol 52 , 1065-1074. \n Caillol M, Mondain-Monval M, Meunier M et al . (1992) Influence of season of birth on onset \nof gonadotrophic and ovarian func tions in young doe hares ( Lepus europaeus ). J \nReprod Fertil 96 , 747-753. \n Duque JC, Oleskovicz N, Guirro EC et al. (2008) Relative potency of ketamine and S(+)-\nketamine in dogs. J Vet Pharmacol Ther 31 , 344-348. \n Erhardt W, Wohlrab S, Kilic N et al. (2001) Comparison of the Anesthesia combinations \nracemic ketamine/medetomidine and S-Ketamine/medetomidine in Syrian golden hamsters ( Mesocricetus auratus ) in Veterinary Anaesthesia nad Analgesia 28, 212-\n213. \n Erhardt W, Henke J & Haberstroh J et al. (2004) An\u00e4sthesie und Analgesie beim Klein- und \nHeimtier sowie bei V\u00f6geln. Schattauer, Stuttgart. \n Finck AD, Ngai SH (1982) Opiate receptor media tion of ketamine analgesia. Anesthesiology \n56, 291-297. \n \nFurtado MM, Nunes AL, Intelizano TR et al. (2010) Comparison of racemic ketamine versus \n(S+) ketamine when combined with midazolam for anesthesia of Callithrix jacchus  \nand Callithrix penicillata . J Zoo Wildl Med 41 , 389-394. \n Flecknell PA (2009) Laboratory animal Anesthesia. Elsevier, London, UK.  Grint NJ, Murison PJ (2008) A compar ison of ketamine-midazolam and ketamine-\nmedetomidine combinations for induction of anaesthesia in rabbits. Vet Anaesth Analg 35 , 113-121. \n Grizmek B (2003) Hares and rabbits. In: A. M. C. M. Hutchins DGK, Valerius Geist (ed). \nGrzimek \u2019s Animal Life Ency clopedia,Vol. 16. Gale Group, Farmington Hills, MI., \n505-516. \n \nGustavsson I (1972) Mitotic and meiotic chromosomes of the variable hare ( Lepus timidus \nL.), the common hare ( Lepus europaeus Pall. ) and their hybrids. Hereditas 67 , 27-34. \n Hedenqvist P, Roughan JV, Orr HE et al. (2001) Assessment of ketamine/medetomidine \nanaesthesia in the New Zealand White rabbit. Veterinary Anaesthesia and Analgesia, 28(1), 18-25. \n  \n28 \n Hedenqvist P, Orr HE, Roughan JV et al. (2002 ) Anaesthesia with ketamine/medetomidine in \nthe rabbit: influence of route of administra tion and the effect of combination with \nbutorphanol. Veterinary Anaesthesia and Analgesia, 29(1), 14-19. \n Hempelmann G, Kuhn DF (1997) Clinical significance of S(+)-ketamine. Anaesthesist 46 \nSuppl 1 , 3-7. \n Hummler HD, Engelmann A, Poh landt F et al. (2006) Decreased accuracy of pulse oximetry \nmeasurements during low perfusion caused by sepsis: Is the perfusion index of any value? Intensive Care Med 32 , 1428-1431. \n Hunter RP, Isaza R (2008) Concepts and issues with interspecies scaling in zoological \npharmacology. J Zoo Wildl Med 39 , 517-526. \n Kharasch ED, Herrmann S, Labroo R (1992) Ketamine as a probe for medetomidine \nstereoisomer inhibition of human liver mi crosomal drug metabolism. Anesthesiology \n77, 1208-1214. \n Kharasch ED & Labroo R (1992) Metabolism of ketamine stereoisomers by human liver \nmicrosomes. Anesthesiology 77 , 1201-1207. \n Kili\u00e7 N, (2004) A Comparison between Medetomidine-Ketamine and Xylazine-Ketamine \nAnaesthesia in Rabbits. Turkish Journal of Veterinary and Animal Sciences, 28, 921-926. \n Kili\u00e7 N & Henke J (2004) Comparative St udies on the Effect of S(+)-Ketamine-\nMedetomidine and Racemic Ketamine-Medeto midine in Mouse. YY\u00dc Vet Fak Derg, \n15, 15-17. \n \nKress HG (1997) Mechanisms of action of ketamine. Anaesthesist 46 Suppl 1 , 8-19. \n Larenza MP, Knobloch M, Landoni MF et al. (2008) Stereoselective pharmacokinetics of \nketamine and norketamine after racemic ke tamine or S-ketamine administration in \nShetland ponies sedated with xylazine. Vet J 177 , 432-435. \n Marietta MP, Way WL, Castagnoli N Jr. et al . (1977) On the pharmacology of the ketamine \nenantiomorphs in the rat. J Pharmacol Exp Ther 202 , 157-165. \n Muir WW, Hubell JAE, Bednarski RM et al . (2007) Handbook of Veterinary Anesthesia. \nMosby, Inc., St.Louis, Missouri. \n Orr HE, Roughan JV, Flecknell PA (2005) Assessment of ketamine and medetomidine \nanaesthesia in the domestic rabbit. Vet Anaesth Analg 32 , 271-279. \n Portier KG, Sena A, Senior M et al. (2010) A study of the co rrelation between objective and \nsubjective indices of recovery quality af ter inhalation anaesthesia in equids. Vet \nAnaesth Analg 37 , 329-336. \n \nRiviere J & Papich E (2009) Veterinary Pharmacology & Therapeutics. Wiley-Blackwell, \nAmes, Iowa.  \n29 \n  \nR\u00f6llig R (2008) Experimental study on superconception (superfetation) in European brown \nhares ( Lepus europaeus Pallas , 1778)  Berlin, Freie Univ., Diss., 2009, 158, XXII S  \n \nRossetti RB, Gaido Cortopassi SR, Intelizano T et al. (2008) Comparison of ketamine and \nS(+)-ketamine, with romifidine and diazep am, for total intravenous anesthesia in \nhorses. Vet Anaesth Analg 35 , 30-37. \n West G, Heard, D, Caulkett N (2009) Zoo Animal & Wildlife Immobilization and Anesthesia. \nBlackwell Publishing, Ames, Iowa. \n White PF, Ham J, Way WL et al. (1980) Pharmacology of ketamine isomers in surgical \npatients. Anesthesiology 52 , 231-239. \n White PF, Way WL, Trevor AJ (1982) Ketamine - its pharmacology and therapeutic uses. \nAnesthesiology 56 , 119-136. \n Wright M (1982) Pharmacologic effects of ketami ne and its use in veter inary medicine. J Am \nVet Med Assoc 180 , 1462-1471. \n Ypsilantis P, Didilis VN, Politou M et al . (2005) A comparative study of invasive and \noscillometric methods of arterial blood pre ssure measurement in the anesthetized \nrabbit. Res Vet Sci 78 , 269-275. \n \n \n  \n \n \n    \n \n     \n \n \n    \n  \n30 \n Tables  \n  Table 1:  Number of animals per group; S-M, S(+)-ketamine (15 mg kg\n-1) + medetomidine \n(0.2 mg kg-1) intra muscular (IM); K-M, ketamine (30 mg  kg-1) + medetomidine (0.2 mg    \nkg-1) IM; Animals = the number (n) of animals in the study including their condition (excited / \ncalm); Weight = the mean \u00b1 SD weight (in grams = g), per group.   \n  S-M K-M \nAnimals (n)  10 10 \nexcited(n) 4 3 \ncalm(n) 6 7 \nWeight (g)  3307  \u00b1 321  3413  \u00b1 369  \n \n \n          \n \n             \n \n      \n31 \n Table 2:  Comparison of maintenance data. Measurements were recorded every 5 minutes: \nValues are mean \u00b1 SD over the anesthe tic period. S-M, S(+)-ketamine (15 mg kg-1) + \nmedetomidine (0.2 mg kg-1) intra muscular (IM); K-M, ketamine (30 mg kg-1) + \nmedetomidine (0.2 mg  kg-1) IM; p = significant differences between groups; HR= heart rate \n(beats minute-1) ; SAP = systolic arterial blood pressure (mmHg); MAP = mean arterial blood \npressure (mmHg); DAP = diastolic arterial bl ood pressure (mmHg); temp =  body temperature \n(\u00b0C); SpO \u2082 = oxygen saturation of arterial hemoglobin (%); etCO \u2082 = side stream expiratory \nCO\u2082 (mmHG); RR = respiratory rate (breaths minute-1). * = Mann-Whitney test applied; n.s. = \nnot significant.  \n  \n S-M K-M p \nHR \n(bpm)  121 \u00b1 31  125 \u00b1 17  0.38 n.s.  \nSAP  \n(mmHg)  109 \u00b1 20  104 \u00b1 24  0.26* n.s.  \nMAP  \n(mmHg)  82 \u00b1 21  77 \u00b1 21  0.18* n.s.  \nDAP \n(mmHg)  63 \u00b1 19  57 \u00b1 19  0.07* n.s.  \ntemp  \n(\u00b0C) 39.9 \u00b1 0.9  39.6 \u00b1 1.4  0.13 n.s.  \nSpO\u2082 \n(%) 82 \u00b1 6  79 \u00b1 9  0.03 \netCO\u2082 \n(mmHg)  39 \u00b1 7  41 \u00b1 5  0.02 \nRR \n(bpm) 40 \u00b1 16  34 \u00b1 12  0.03*  \n \n  \n \n     \n \n     \n  \n32 \n Table 3:  Values are presented as mean (\u00b1SD). S-M, S(+)-ketamine (15 mg kg-1) + \nmedetomidine (0.2 mg kg-1) intra muscular (IM); K-M, ketamine (30 mg kg-1) + \nmedetomidine (0.2 mg kg-1) IM. T - Anest = Total anesthesia time (minutes); T - standing = \nTime from antagonization until standing on four feet (minutes); T - Recov = Total recovery time (minutes); Falling = Number of events (n) of falling over to the side; Pedaling = Number \nof events (n) of pedaling while in lateral recumbency and Quality (VAS) = Quality of \nrecovery by measurement of visual analogue  scale mark (in mm). Compared by group for \nsignificant differences (p). * = Mann-Whitney test applied; n.s. = not significant.   \n  S-M K-M p \nT - Anest  \n(minutes) 65 \u00b1 13  70  \u00b1 22  0.68* n.s.  \nT - Standing  \n(minutes)  30  \u00b1 25  34  \u00b1 23  0.58* n.s.  \nT - Recov  \n(minutes)  129  \u00b1 25  148.5  \u00b1 25  0.10 n.s.  \nFalling  \n(n) 12.5 \u00b1 6.7  27.2  \u00b1 12.56  0.01 \nPedaling  \n(n) 6.3  \u00b1 5.4  13.3  \u00b1 10.8  0.10 n.s.  \nQuality (VAS)  \n(mm) 47.7 \u00b1 15.2  35.4  \u00b1 22.3  0.17 n.s.  \n  \n \n \n \n             \n \n   \n \n \n  \n33 \n Figures \n \n \nFigure 1:  Mean times (minutes) (\u00b1 SD) until firs t effect (T-Reaction) and loss of righting \nre\ufb02ex (T-Effect); compared between groups (S-M  / K-M) receiving: S-M, S(+)-ketamine (15 \nmg kg-1) + medetomidine (0.2 mg kg-1) intra muscular (IM); K-M, ketamine (30 mg kg-1) + \nmedetomidine (0.2 mg kg-1) IM. \n     \n 02468101214\nT-Reaction T-EffectTime (minutes)Figure 1\nInduction times\nS-M K-M \n34 \n  \nFigure 2a):  Mean heart rate (beats minute-1) over time (minutes) compared between groups \n(S-M / K-M) receiving: S-M, S(+)-ketamine (15 mg kg-1) + medetomidine (0.2 mg   kg-1) \nintra muscular (IM); K-M, ketamine (30 mg kg-1) + medetomidine (0.2 mg kg-1) IM. 90100110120130140150\n5 10 15 20 25 30 35 40 45Heart rate  (beats minute-1)\nTime (minutes)Fig 2 a)\nMean heart rate over time\nS-M K-M \n35 \n  \nFigure 2b):  Mean systolic arterial blood pressure  (mmHg) over time (minutes) compared \nbetween groups (S-M / K-M) receiving: S-M, S(+)-ketamine (15 mg kg-1) + medetomidine \n(0.2 mg kg-1) intra muscular (IM); K-M, ketamine (30 mg kg-1) + medetomidine (0.2 mg kg-1) \nIM.  \n 80859095100105110115120125130\n0 5 10 15 20 25 30 35 40 45SAP (mmHg)\nTime (minutes)Figure 2 b)\nSystolic arterial blood pressure (SAP) over time\nS-M K-M \n36 \n  \nFigure 2c):  Mean expiratory CO 2 (mmHg) over time (minutes) compared between groups (S-\nM / K-M) receiving: S-M, S(+)-ketamine (15 mg kg-1) + medetomidine (0.2 mg kg-1) intra \nmuscular (IM); K-M, ketamine (30 mg kg-1) + medetomidine (0.2 mg kg-1) IM. \n \n 303234363840424446\n5 10 15 20 25 30 35 40 45etCO 2(mmHg)\nTime (minutes)Figure 2 c)\nSide stream expiratory CO2 (etCO 2) over time \nS-M K-M \n37 \n  \nFigure 2d):  Mean respiratory rate (breaths minute-1) over time (minutes) compared between \ngroups (S-M / K-M) receiving: S-M, S(+)-ketamine (15 mg kg-1) + medetomidine (0.2 mg  \nkg-1) intra muscular (IM); K-M, ketamine (30 mg kg-1) + medetomidine (0.2 mg kg-1) IM. \n             \n \n     \n 253035404550\n5 10 15 20 25 30 35 40 45Respiratory rate (breaths minute-1)\nTime (minutes)Figure 2 d)\nRespiratoy rate over time\nS-M K-M \n38 \n  \nFigure 3:  Percentage of animals in surgical anesthesia (animals that showed no reaction to \nthree toe pinch stimuli within 20 seconds ever y five minutes) over time (minutes) compared \nbetween groups (S-M / K-M) receiving: S-M, S(+)-ketamine (15 mg kg-1) + medetomidine \n(0.2 mg kg-1) intra muscular (IM); K-M, ketamine (30 mg kg-1) + medetomidine (0.2 mg kg-1) \nIM. \n    0102030405060708090100\n5 1 01 52 02 53 03 54 04 550Animals in surgical anesthesia (%)\nTime (minutes)Figure 3\nPercentage of animals in surgical anesthesia per point of time\nS-M K-M \n39 \n             \n \nFigure 4:  Recovery parameter values, presente d as mean (\u00b1SD). Quality VAS = The \nmeasurement (mm) of a visual analogue scale mark for subjective recovery quality assessment; Falling  = The number of  events (n) the hare fell over to the side during recovery; \nPedaling = The number of events the hare  was pedaling while in lateral recumbency; \ncompared between groups (S-M / K-M) receiving: S-M, S(+)-ketamine (15 mg kg\n-1) + \nmedetomidine (0.2 mg kg-1) intra muscular (IM); K-M, ketamine (30 mg kg-1) + \nmedetomidine (0.2 mg kg-1) IM; Falling = The number of events the animal fell over during \nrecovery; Pedaling =  The number of events the animal was pedaling while in lateral position \nduring recovery.  \n \n            \n \n     \n \n 010203040506070\nQuality V AS Falling Pedaling Figure 4\nQuality of recovery\nS-M K-MVAS (mm)    Events (n) \n40 \n Summary \n \nThis is a comparative study of two anesth etic protocols based on medetomidine in \ncombination with either racemic ketamine or S(+)-ketamine in the European brown hare \n(EBH) ( Lepus europaeus). \nAvailability of tested protocols for wildlife that is of interest for research purposes deems \nnecessary. Literature based anesthetic regimens used for the EBH in the past did not seem \nadequate anymore. \nSince Lagomorphs are known for higher anesthetic risk it was tried to develop a protocol that \nwould reliably produce safe, surgical anesthesia with a brief recovery period, suitable for field \nanesthesia. \n20 EBHs were anesthetized for routine procedures. All parameters recorded in the study were \nsubject to statistical analysis . Times until first and full effect were recorded and during \nmaintenance the animals' vital parameters were measured in a five minute interval. Special \nfocus was set on recovery parameters. Total an esthesia time, Standing time and Recovery \ntime were noted. Additionally, the number of times  the animal fell over or was pedaling in \nlateral position were recorded. A visual analogue scale was used for subj ective assessment of \nrecovery quality. All personnel evaluating anesth esia were blinded about the protocol used.  \nAt the dosages of 15 mg kg-1 S(+)-ketamine or 30 mg kg-1 racemic ketamine in combination \nwith 0.2 mg kg-1 medetomidine did not reliably produce surgical anesthesia. Overall, animals \nreceiving the racemic ketamine reached a deeper state of anesthesia and had more respiratory \ndepression than the S(+)-ketamine group. Unfo rtunately, the idea of using S(+)-ketamine \ninstead of racemic ketamine did not markedl y improve recovery. Even though slight \nimprovements were noted in the S(+)-ketamine group, recovery frequently exceeded two \nhours in both groups. Recovery in most cases was accompanied by uncoordinated movements \nand involuntary motoractivity. We conclude that further research is needed to develop an \ninjectable field anesthesia protocol for the EBH that guarantees surgical anesthesia while \nproducing minimal unwanted side effects during recovery and therefore diminishes animal \nwelfare issues.  \n41 \n Zusammenfassung \nDies ist eine Vergleichsstudie zweier Protokolle zur Feld-Narkose des Europ\u00e4ischen \nFeldhasen (EFH) ( Lepus europaeus ). Es wurde die Wirkung von 0,2 mg kg-1 Medetomidin in \nKombination mit entweder 15 mg kg-1 S-(+)-Ketamin oder 30 mg kg-1 razemischem Ketamin \nverglichen. \nSpezies-spezifische An\u00e4sthesie ist vor allem f\u00fcr Wildtiere angebracht, die im \nForschungsinteresse stehen. Gro\u00dfe tierartliche Unterschiede im Bereich der \nHaustieran\u00e4sthesie sind hinl\u00e4nglich bekannt. Einfache \u00dcbertragung von Haustierprotokollen \nauf Wildtiere hat sich in der Verg angenheit als ungen\u00fcgend dargestellt. \nIm Rahmen einer Routineuntersuchung wurden  20 Feldhasen des Forschungsinstituts f\u00fcr \nWildtierkunde und \u00d6kologie der Veterin\u00e4rmedizini schen Universit\u00e4t Wien in zwei Gruppen \u00e1 \n10 Tiere aufgeteilt und mit einem der oben  erw\u00e4hnten Protokolle an\u00e4sthesiert. \nErstreaktionszeit, sowie die Zeit bis zum vollen Effekt (Verlust des Stell-Reflexes) wurden \ndokumentiert und verglichen. W\u00e4hrend der An\u00e4sth esie wurden die Vitalparameter der Tiere \nalle 5 Minuten kontrolliert und im Anschluss an die Studie statistisch ausgewertet. Besonderes \nAugenmerk wurde auf die Parameter der Aufwach- und Erholungsphase gelegt. Da es sich um \nein Protokoll f\u00fcr eine Feldnarkose handelt, wurden Narkosezeit, Aufstehzeit und \nRegenerationszeit gemessen und zwischen beid en Gruppen verglichen. Zus\u00e4tzlich wurde \ngez\u00e4hlt, wie oft die Tiere in der Erholungsphase  umfielen oder in Seitenlage ruderten, um ein \nMa\u00df f\u00fcr eingeschr\u00e4nkte Koordinationsf\u00e4higkeit zu schaffen. Zusammen mit einer visuellen \nanalogen Skala zur subjektiven Einsch\u00e4tzung der Qualit\u00e4t der Aufwachphase, wurden auch \ndiese Werte auf signifikante Unterschiede zwischen den beiden Gruppen untersucht. \nTiere, die razemisches Ketamin als Komponente bekommen hatten, erreichten ein tieferes \nAn\u00e4sthesiestadium als die Tiere aus der S-(+)-Ketamin Gruppe. Die respiratorischen \nParameter in der S-(+)-Ketamin Gruppe waren signifikant besser. Insgesamt wurde jedoch in \nkeiner Gruppe die chirurgische Toleranz verl \u00e4sslich erreicht. Eine lange Aufwachphase mit \nteils hochgradigen unkoordinierten und unfreiwilligen Bewegungen wurde hingegen \nregelm\u00e4\u00dfig beobachtet. \nDie Nutzung des S-(+)-Isomers des Ketamins br achte hinsichtlich der Aufwachphase zwar \ngeringf\u00fcgige, aber keine klinisch relevante n Vorteile gegen\u00fcber dem razemischen Gemisch. \nEs bedarf daher weiterer Untersuchungen um  ein, f\u00fcr den EFH geeignetes, Protokoll zur \nFeldnarkose zu entwickeln. Eine sichere An\u00e4s thesie mit chirurgischer Toleranz und einer  \n42 \n kurzen Aufwachphase mit m\u00f6glichst wenigen unerw\u00fcnschten Nebenwirkungen sollte auch \naus Sicht des Tierschutzes das Ziel sein. ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}